Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000071 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 13, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
29,997
Total Value
$1,003,083.33
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Senior Vice President, Finance | Common Stock | โ | Jul 13, 2026 | Exercise/Conversion | 8,541 | $12.50 | $106,762.50 | 23,853 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Jul 13, 2026 | Exercise/Conversion | 1,458 | $34.39 | $50,140.62 | 25,311 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Jul 13, 2026 | Sale | 300 | $83.07 | $24,919.95 | 25,011 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Jul 13, 2026 | Sale | 3,743 | $84.26 | $315,369.09 | 21,268 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Jul 13, 2026 | Sale | 5,656 | $84.90 | $480,201.19 | 15,612 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Jul 13, 2026 | Sale | 300 | $85.63 | $25,689.99 | 15,312 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | Jul 13, 2026 | Exercise/Conversion | 8,541 | $0.00 | $0.00 | 101,459 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | Jul 13, 2026 | Exercise/Conversion | 1,458 | $0.00 | $0.00 | 61,250 | Direct | โ | View Details |